Hochreuter K, Buti G, Ajdari A, Bridge C, Sharp G, Jespersen S
Phys Imaging Radiat Oncol. 2025; 33:100688.
PMID: 39866246
PMC: 11758580.
DOI: 10.1016/j.phro.2024.100688.
Mohamed Sajer R, Pendem S, Kadavigere R, - P, Nayak S S, Nayak K
F1000Res. 2025; 14():54.
PMID: 39839989
PMC: 11747303.
DOI: 10.12688/f1000research.160088.1.
Lu Y, Du N, Fang X, Shu W, Liu W, Xu X
Cancer Imaging. 2024; 24(1):80.
PMID: 38943156
PMC: 11212435.
DOI: 10.1186/s40644-024-00726-3.
Tropeano M, Raspagliesi L, Bono B, Baram A, Rossini Z, Franzini A
Acta Neurochir (Wien). 2024; 166(1):196.
PMID: 38676720
DOI: 10.1007/s00701-024-06090-2.
Kamimura S, Mitobe Y, Nakamura K, Matsuda K, Kanemura Y, Kanoto M
Surg Neurol Int. 2024; 15:108.
PMID: 38628517
PMC: 11021064.
DOI: 10.25259/SNI_63_2024.
Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion.
De Fazio E, Pittarello M, Gans A, Ghosh B, Slika H, Alimonti P
Int J Mol Sci. 2024; 25(5).
PMID: 38473812
PMC: 10932253.
DOI: 10.3390/ijms25052563.
Integrating multi-modal imaging in radiation treatments for glioblastoma.
Breen W, Aryal M, Cao Y, Kim M
Neuro Oncol. 2024; 26(12 Suppl 2):S17-S25.
PMID: 38437666
PMC: 10911793.
DOI: 10.1093/neuonc/noad187.
The Role of Multimodal Imaging in Differentiating Vasogenic from Infiltrative Edema: A Systematic Review.
Hasanzadeh A, Moghaddam H, Shakiba M, Jalali A, Firouznia K
Indian J Radiol Imaging. 2023; 33(4):514-521.
PMID: 37811185
PMC: 10556327.
DOI: 10.1055/s-0043-1772466.
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
Mantica M, Drappatz J, Lieberman F, Hadjipanayis C, Lunsford L, Niranjan A
J Neurooncol. 2023; 164(1):179-190.
PMID: 37515669
DOI: 10.1007/s11060-023-04398-0.
Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial.
Trivedi A, Ramesh K, Huang V, Mellon E, Barker P, Kleinberg L
Cancers (Basel). 2023; 15(13).
PMID: 37444634
PMC: 10340675.
DOI: 10.3390/cancers15133524.
Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric Study.
Otsuji R, Hata N, Funakoshi Y, Kuga D, Togao O, Hatae R
Neurol Med Chir (Tokyo). 2023; 63(8):364-374.
PMID: 37423755
PMC: 10482486.
DOI: 10.2176/jns-nmc.2022-0351.
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III Studies.
Cho N, Wong W, Nghiemphu P, Cloughesy T, Ellingson B
Curr Oncol Rep. 2023; 25(9):1047-1055.
PMID: 37402043
PMC: 10474988.
DOI: 10.1007/s11912-023-01433-1.
Impact of Postoperative Changes in Brain Anatomy on Target Volume Delineation for High-Grade Glioma.
Dejonckheere C, Thelen A, Simon B, Greschus S, Koksal M, Schmeel L
Cancers (Basel). 2023; 15(10).
PMID: 37345177
PMC: 10216722.
DOI: 10.3390/cancers15102840.
Deep Learning of Time-Signal Intensity Curves from Dynamic Susceptibility Contrast Imaging Enables Tissue Labeling and Prediction of Survival in Glioblastoma.
Yun J, Yun S, Park J, Cheong E, Park S, Kim N
AJNR Am J Neuroradiol. 2023; 44(5):543-552.
PMID: 37105676
PMC: 10171378.
DOI: 10.3174/ajnr.A7853.
The need of radiotherapy optimization for glioblastomas considering immune responses.
Nishioka K, Takahashi S, Mori T, Uchinami Y, Yamaguchi S, Kinoshita M
Jpn J Radiol. 2023; 41(10):1062-1071.
PMID: 37071249
PMC: 10543135.
DOI: 10.1007/s11604-023-01434-x.
An enduring debate on gliomatosis cerebri.
Akimoto J
Brain Tumor Pathol. 2023; 40(2):78-84.
PMID: 37022648
DOI: 10.1007/s10014-023-00454-9.
Predicting regrowth of low-grade gliomas after radiotherapy.
Plaszczynski S, Grammaticos B, Pallud J, Campagne J, Badoual M
PLoS Comput Biol. 2023; 19(3):e1011002.
PMID: 37000852
PMC: 10128962.
DOI: 10.1371/journal.pcbi.1011002.
A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.
Ramesh K, Huang V, Rosenthal J, Mellon E, Goryawala M, Barker P
Tomography. 2023; 9(1):362-374.
PMID: 36828381
PMC: 9964256.
DOI: 10.3390/tomography9010029.
Artificial intelligence-based locoregional markers of brain peritumoral microenvironment.
Riahi Samani Z, Parker D, Akbari H, Wolf R, Brem S, Bakas S
Sci Rep. 2023; 13(1):963.
PMID: 36653382
PMC: 9849348.
DOI: 10.1038/s41598-022-26448-9.
Differentiation of high grade glioma and solitary brain metastases by measuring relative cerebral blood volume and fractional anisotropy: a systematic review and meta-analysis of MRI diagnostic test accuracy studies.
Fioni F, Chen S, Lister I, Ghalwash A, Long M
Br J Radiol. 2022; 96(1141):20220052.
PMID: 36278795
PMC: 10997014.
DOI: 10.1259/bjr.20220052.